Other institutional and public shareholders
Biotech Investor · 3 portfolio companies
Portfolio
3
Combined Value
$6.9B
Focus Areas
7
Top Stage
Phase 3
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Scholar Rock Holding | $5.1B |
| Intellia Therapeutics | $1.5B |
| Kala Pharmaceuticals | $215.8M |